Chatrick Paul of AstraZeneca shares his perspective on the mission to eradicate cancer as a leading cause of death
Chatrick Paul, SVP, Head of US Oncology Business, AstraZeneca
Advertisement
Articles by Chatrick Paul, SVP, Head of US Oncology Business, AstraZeneca
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
5